Clinical trial
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in…
NCT00004859 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00004859 |
|---|---|
| Title | Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer |
| Official title | A Randomized Phase III Trial of Carboplatin, Paclitaxel and Thoracic Radiotherapy, With or Without Thalidomide, in Patients With Stage III Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, paclitaxel, thalidomide, radiation therapy |
| Enrollment | 589 |
| Start date | Jan 1, 2000 |
| Primary completion | Dec 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 2, 2014 |
| Countries | South Africa, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: